Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05492682
Title START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Valo Therapeutics Oy
Age Groups: adult | senior
Covered Countries DEU

No variant requirements are available.